| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/2013 | US20130035475 Methods for Identifying Compounds That Modulate Ion Channel Activity of a Kir Channel |
| 02/07/2013 | US20130035472 Method of producing transcripts using cryptic splice sites |
| 02/07/2013 | US20130035471 Tetrameric Streptavidin Mutein With Reversible Biotin Binding Capability |
| 02/07/2013 | US20130035403 Cells, nucleic acids, enzymes and use thereof, and methods for the production of sophorolipids |
| 02/07/2013 | US20130035376 MCP-1 binding nucleic acids |
| 02/07/2013 | US20130035374 MicroRNA induction of pluripotential stem cells and uses thereof |
| 02/07/2013 | US20130035370 Compositions and methods for modulation of lmna expression |
| 02/07/2013 | US20130035287 Transient immortalization |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130035256 Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods |
| 02/07/2013 | US20130035243 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 02/07/2013 | US20130035233 Novel herbicide resistance genes |
| 02/07/2013 | US20130034907 Biological circuit chemotactic converters |
| 02/07/2013 | US20130034906 Methods for in vitro oocyte maturation |
| 02/07/2013 | US20130034897 Bacterial host cell for the direct expression of peptides |
| 02/07/2013 | US20130034895 Ketoreductase polypeptides for the production of azetidinone |
| 02/07/2013 | US20130034894 Novel allene oxide synthase derived from lemna paucicostata |
| 02/07/2013 | US20130034890 Polypeptides Having Cellobiohydrolase 1 Activity and Polynucleotides Encoding Same |
| 02/07/2013 | US20130034886 Pseudomonas aeruginosa strain developed for improving fatty acid content, and method of manufacturing the same |
| 02/07/2013 | US20130034882 Minicircle dna vector preparations and methods of making and using the same |
| 02/07/2013 | US20130034878 Chondroitin Synthase, Method for Producing The Same and Method for Producing Saccharide Chain-Extended Chondroitin |
| 02/07/2013 | US20130034875 Dna construct, and process for production of recombinant cho cell using same |
| 02/07/2013 | US20130034848 Tumor suppressor gene p33ing2 |
| 02/07/2013 | US20130034627 Lipid acyltransferase proteins and methods of making them |
| 02/07/2013 | US20130034585 Bovine Herpes Virus Vaccine With Multiple Mutations |
| 02/07/2013 | US20130034583 Compositions, methods and uses for expression of enterobacterium-associated peptides |
| 02/07/2013 | US20130034578 Recombinant multimeric influenza proteins |
| 02/07/2013 | US20130034576 Novel adenovirus isolated from titi monkeys |
| 02/07/2013 | US20130034575 Method for identification, isolation and production of antigens to a specific pathogen |
| 02/07/2013 | US20130034574 Modified melk peptides and vaccines containing the same |
| 02/07/2013 | US20130034564 Anti-rsv g protein antibodies |
| 02/07/2013 | US20130034560 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same |
| 02/07/2013 | US20130034559 Targeted Binding Agents Against B7-H1 |
| 02/07/2013 | US20130034558 Epidermal growth factor receptor variant |
| 02/07/2013 | US20130034552 Temperature sensitive conjugate compositions, and uses related thereto |
| 02/07/2013 | US20130034527 Mitochondrial enhancement of cells |
| 02/07/2013 | US20130034525 Beta iselets-like cells derived from whole bone marrow |
| 02/07/2013 | CA2853849A1 Protein having activity to promote fatty acid chain elongation, gene encoding the same and use thereof |
| 02/07/2013 | CA2848369A1 Fusion gene of kif5b gene and ret gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 02/07/2013 | CA2845317A1 Saliva collection, processing, stabilization, and storage method |
| 02/07/2013 | CA2844355A1 Axmi279 pesticidal gene and methods for its use |
| 02/07/2013 | CA2844197A1 Treatment of fibrosis using microrna-19b |
| 02/07/2013 | CA2844132A1 Hypoxia-related gene signatures for cancer classification |
| 02/07/2013 | CA2844101A1 Methods and compositions for targeted integration in a plant |
| 02/07/2013 | CA2844042A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844040A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844038A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844034A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844033A1 Method for detecting pancreatic cancer |
| 02/07/2013 | CA2844030A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2844012A1 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| 02/07/2013 | CA2843931A1 Terminator sequence for gene expression in plants |
| 02/07/2013 | CA2843915A1 Method for high-throughput screening of transgenic plants |
| 02/07/2013 | CA2843905A1 Cell free translation system for compound screening and related uses |
| 02/07/2013 | CA2843896A1 Collagen 7 and related methods |
| 02/07/2013 | CA2843552A1 Protein having activity to promote fatty acid chain elongation, gene encoding the same and use thereof |
| 02/07/2013 | CA2843430A1 Assay for detection of jc virus dna |
| 02/07/2013 | CA2843386A1 Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct |
| 02/07/2013 | CA2843064A1 A pentose sugar fermenting cell |
| 02/07/2013 | CA2842954A1 Double-stranded oligonucleotide compounds for treating hearing and balance disorders |
| 02/07/2013 | CA2842872A1 Recombinant swine influenza virus and uses thereof |
| 02/07/2013 | CA2842722A1 Organelle targeting nanocarriers |
| 02/07/2013 | CA2842706A1 Method for systemically influencing processes in the male meiocyte |
| 02/07/2013 | CA2842368A1 Switch costimulatory receptors |
| 02/07/2013 | CA2842092A1 Method for identification and isolation of terminator sequences causing enhanced transcription |
| 02/07/2013 | CA2841250A1 Phosphatidic acid phosphatase gene |
| 02/07/2013 | CA2828638A1 Powdery mildew resistance providing genes in cucumis sativus |
| 02/06/2013 | EP2554681A1 Constitution of tool for analyzing biomolecular interaction and analysis method using same |
| 02/06/2013 | EP2554680A1 Method for distinguishing target base sequence |
| 02/06/2013 | EP2554675A1 Method of manufacturing zeaxanthin by fermentation |
| 02/06/2013 | EP2554674A1 Trichome specific promoters |
| 02/06/2013 | EP2554673A1 Novel monoclonal antibody and method for immunoassaying d dimer |
| 02/06/2013 | EP2554672A1 Nucleic acid structure, method for producing complex using same, and screening method |
| 02/06/2013 | EP2554671A1 Novel allene oxide synthase derived from lemna paucicostata |
| 02/06/2013 | EP2554670A1 Plasmid vector |
| 02/06/2013 | EP2554669A1 Novel antibody having modification site introduced therein, and antibody fragment |
| 02/06/2013 | EP2554668A1 A pentose sugar fermenting cell |
| 02/06/2013 | EP2554659A1 Method for preparing es cells |
| 02/06/2013 | EP2554552A1 Novel anti-cd98 antibody and use thereof |
| 02/06/2013 | EP2554550A1 Method for inhibiting hiv replication in mammal and human cells |
| 02/06/2013 | EP2554182A1 Mammal sestrins in the treatment of muscle wasting |
| 02/06/2013 | EP2554045A1 Method for systemically influencing processes in the male meiocyte |
| 02/06/2013 | EP2553453A1 Tools for the identification of lingo-1, lingo-2, lingo-3 and lingo-4, ligands, and uses thereof |
| 02/06/2013 | EP2553106A2 Pharmacologically induced transgene ablation system |
| 02/06/2013 | EP2553105A1 Compositions and methods for the production of recombinant virus vectors |
| 02/06/2013 | EP2553104A1 Plants having enhanced yield-related traits and method for making the same |
| 02/06/2013 | EP2553103A1 Protein production in filamentous fungi |
| 02/06/2013 | EP2553102A2 High level expression of recombinant toxin proteins |
| 02/06/2013 | EP2553101A2 Protease activated cytokines |
| 02/06/2013 | EP2553099A1 Macrocyclic lactone resistance marker for dirofilaria immitis |
| 02/06/2013 | EP2553098A2 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3 |
| 02/06/2013 | EP2553097A1 Controlled release hybrid systems |
| 02/06/2013 | EP2553096A1 Ect2 peptides and vaccines including the same |
| 02/06/2013 | EP2553094A2 Novel cbh1-eg1 fusion proteins and use thereof |
| 02/06/2013 | EP2553091A1 Thermostable phytase variants |
| 02/06/2013 | EP2553090A2 Thermostable phytase variants |
| 02/06/2013 | EP2552965A2 Anti-cd40 antibodies |
| 02/06/2013 | EP2552959A2 Antibodies to muc16 and methods of use thereof |
| 02/06/2013 | EP2552957A1 Antibodies with enhanced or suppressed effector function |
| 02/06/2013 | EP2552949A2 Methods for g-csf production in a pseudomonas host cell |